Telaprevir

Telaprevir is associated with a higher incidence of skin rashes, while boceprevir may reduce blood counts and lead to anemia and other side effects.

Strides Against Hepatitis C Open Door to Blockbusters Jonathan D. Rockoff 2010

Indeed, FDA staff members suggested the agency was leaning toward approving boceprevir and a similar product, telaprevir, from Vertex Pharmaceuticals Inc. Telaprevir will be reviewed Thursday by the same FDA panel.

FDA Panel Backs Merck Hepatitis C Drug Jennifer Corbett Dooren 2011

Telaprevir and boceprevir are among so-called protease inhibitors that try to block the virus from replicating.

Strides Against Hepatitis C Open Door to Blockbusters Jonathan D. Rockoff 2010

On Data for Hepatitis Drug NEW YORK -- Shares of Vertex Pharmaceuticals were up 23% Monday after it released positive data on its closely watched Telaprevir, an oral medication in development to treat hepatitis C.

Shares of Vertex Increase 2008

In addition, shares of Vertex Pharmaceuticals gained 5.23, or 28%, to 23.89 after it released positive data on Telaprevir, an oral medication in development to treat hepatitis C.

Schering-Plough and Merck Decline 2008

Test data on Telaprevir, Vertex's hepatitis-C drug, indicate it could cure 50% more patients than existing treatments, and in half the time.

Rx for Ailing Investors? 2008

Shares of Vertex Pharmaceuticals surged 16% in afternoon trading Friday after the company announced promising clinical data for lead drug candidate Telaprevir, an experimental hepatitis C treatment.

Big Pharma Stocks Decline On Pipeline Setbacks 2006

Telaprevir is being developed for the treatment of hepatitis C virus HCV, for both treatment-naïve and treatment-failed patients.

Vertex Expects an Eventful 2011 - Yahoo! Finance 2011

Telaprevir slightly increased the exposure to ritonavir-boosted atazanavir.

unknown title 2011

Telaprevir is an investigational, oral inhibitor that acts directly on the HCV protease, an enzyme essential for viral replication.

unknown title 2011